Amplia Therapeutics Limited (ASX:ATX – Get Free Report) insider Robert Peach bought 827,268 shares of the stock in a transaction dated Wednesday, June 19th. The shares were bought at an average cost of A$0.06 ($0.04) per share, with a total value of A$45,499.74 ($30,333.16).
Amplia Therapeutics Price Performance
The company has a quick ratio of 5.05, a current ratio of 3.43 and a debt-to-equity ratio of 15.18.
About Amplia Therapeutics
Want More Great Investing Ideas?
Read More
- Five stocks we like better than Amplia Therapeutics
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- Russell 2000 Index, How Investors Use it For Profitable Trading
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- ETF Screener: Uses and Step-by-Step Guide
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Amplia Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplia Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.